(Q33889422)

29 July 2017

title

hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure (English)

1 reference

29 July 2017

0 references

1 reference

chronic heart failure

1 reference

Päivi Lakkisto

3

0 references

Ari Harjula

object named as

Ari Harjula

10

0 references

Esko Kankuri

object named as

Esko Kankuri

9

0 references

Tommi Pätilä

5

object named as

Tommi Pätilä

1 reference

29 July 2017

Antti Siltanen

1

1 reference

29 July 2017

Katsukiyo Kitabayashi

2

1 reference

29 July 2017

Johanna Mäkelä

4

1 reference

29 July 2017

Masamichi Ono

6

1 reference

29 July 2017

Ilkka Tikkanen

7

1 reference

29 July 2017

Yoshiki Sawa

8

1 reference

29 July 2017

language of work or name

English

0 references

publication date

26 April 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

6

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

e19161

1 reference

Creative Commons Attribution 4.0 International

29 July 2017

copyright license

start time

26 April 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3082550/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Stem cell therapy in cardiovascular disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082550

Bcl-2 expression enhances myoblast sheet transplantation therapy for acute myocardial infarction.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082550

Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082550

Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082550

Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082550

Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082550

Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082550

Emerging multipotent aspects of hepatocyte growth factor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082550

Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets.

5 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019161

Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019161

Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019161

Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019161

Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019161

Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082550

Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats

29 October 2018

1 reference

12 December 2020

Bcl-2 improves myoblast sheet therapy in rat chronic heart failure

1 reference

12 December 2020

A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats

1 reference

12 December 2020

Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle

1 reference

12 December 2020

Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model

1 reference

12 December 2020

Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats

1 reference

12 December 2020

Gene transfer of hepatocyte growth factor improves angiogenesis and function of chronic ischemic myocardium in canine heart

1 reference

12 December 2020

Serum hepatocyte growth factor levels are increased in patients with congestive heart failure

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0019161

Identifiers

DOI

1 reference

29 July 2017

0 references

1 reference

29 July 2017

1 reference